Open Label: Clinical Trials

2 trials for Open Label, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2

Follow Open Label: new trials by email Literature Review of Open Label trials Research Report on Open Label

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants
TNX-102 SL Tablet - Pharmakokinetic, Open Label
Phase 1Active not recruitingTonix Pharmaceuticals, Inc.502025-12-092026-02-17
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
FX-909, Pembrolizumab (KEYTRUDA ®), KEYTRUDA ®( Pembrolizumab) - Advanced Urothelial Carcinoma, Oral Drug Administration
Phase 1Active not recruitingFlare Therapeutics Inc.1202023-08-242026-08-12

Interventions

pembrolizumab (1)

Sponsors

Flare Therapeutics Inc. (1)  ·  Tonix Pharmaceuticals, Inc. (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Dan Rudin, MD (1)  ·  Gopa Iyer, MD (1)

Results publications

PMID 41760953